Microfluidic Platform Devised for Determination of Autism Biomarker
By LabMedica International staff writers Posted on 27 Nov 2017 |
Image: A CPK model of the oxytocin molecule (Photo courtesy of Wikimedia Commons).
A team of Polish scientists has devised a unique electrochemical microfluidic platform for determination of the autism biomarker oxytocin.
Significant changes of oxytocin concentration in the blood are considered to be a biomarker of autism. To monitor these changes in a rapid and convenient manner, investigators at the Institute of Physical Chemistry of the Polish Academy of Sciences (Warsaw, Poland) used the technique of molecular imprinting to construct a microfluidic platform for measurement of oxytocin levels.
The device comprised monomer layers of polymer that were pocketed with oxytocin shaped nanocavities. The monolayers were coated onto small gold electrodes that were inserted into a tube containing a blood sample. Entrapment of oxytocin molecules in the cavities of the polymer layer changed the electrical capacitance of the polymer and indicated the level of oxytocin binding.
The investigators demonstrated that sensitivity of the system was similar in both synthetic serum samples and in aqueous solutions and, that the measurement was not susceptible to common interferences, such as oxytocin analogs and potential metabolites.
The investigators did point out that oxytocin concentration is only one biomarker for autism, and several other diagnostic tests need to be performed. Towards this end, they have been working on polymer layers that respond to two other autism-associated compounds, melatonin and gamma-aminobutyric acid.
The oxytocin detection platform was described in detail in the September 9, 2017, online edition of the journal Biosensors and Bioelectrics.
Related Links:
Institute of Physical Chemistry of the Polish Academy of Sciences
Significant changes of oxytocin concentration in the blood are considered to be a biomarker of autism. To monitor these changes in a rapid and convenient manner, investigators at the Institute of Physical Chemistry of the Polish Academy of Sciences (Warsaw, Poland) used the technique of molecular imprinting to construct a microfluidic platform for measurement of oxytocin levels.
The device comprised monomer layers of polymer that were pocketed with oxytocin shaped nanocavities. The monolayers were coated onto small gold electrodes that were inserted into a tube containing a blood sample. Entrapment of oxytocin molecules in the cavities of the polymer layer changed the electrical capacitance of the polymer and indicated the level of oxytocin binding.
The investigators demonstrated that sensitivity of the system was similar in both synthetic serum samples and in aqueous solutions and, that the measurement was not susceptible to common interferences, such as oxytocin analogs and potential metabolites.
The investigators did point out that oxytocin concentration is only one biomarker for autism, and several other diagnostic tests need to be performed. Towards this end, they have been working on polymer layers that respond to two other autism-associated compounds, melatonin and gamma-aminobutyric acid.
The oxytocin detection platform was described in detail in the September 9, 2017, online edition of the journal Biosensors and Bioelectrics.
Related Links:
Institute of Physical Chemistry of the Polish Academy of Sciences
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability